Immune Therapeutics, Inc. is a drug development and commercialization company. The Company identifies, evaluates and seeks to acquire technologies in the medical device and drug development sectors. The Company executed two licenses, which are Cytocom, Inc. (Cytocom) and Forte Animal Health, Inc. (Forte).
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Annual Dividend Rate
Price/Cash Flow (TTM)